HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiki Tokura Selected Research

nadifloxacin

8/2013Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris.
12/2011Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.
5/2006Nadifloxacin downmodulates antigen-presenting functions of epidermal Langerhans cells and keratinocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiki Tokura Research Topics

Disease

21Atopic Dermatitis (Atopic Eczema)
06/2021 - 11/2002
19Neoplasms (Cancer)
04/2021 - 08/2002
17Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 11/2008
16Hypersensitivity (Allergy)
01/2022 - 05/2002
14Contact Dermatitis (Eczema, Contact)
01/2020 - 04/2002
10Drug Eruptions (Drug Eruption)
01/2022 - 09/2006
9Photoallergic Dermatitis (Photoallergy)
12/2021 - 08/2003
9Skin Diseases (Skin Disease)
04/2015 - 04/2002
8Urticaria (Hives)
08/2021 - 11/2010
8Melanoma (Melanoma, Malignant)
10/2019 - 04/2010
7Hypohidrosis
08/2021 - 01/2011
7Inflammation (Inflammations)
09/2019 - 01/2007
7Mycosis Fungoides
01/2018 - 06/2005
6Dermatitis
10/2022 - 05/2010
6Neoplasm Metastasis (Metastasis)
09/2018 - 08/2010
6Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2014 - 03/2005
6Acne Vulgaris
08/2013 - 08/2003
5Alopecia Areata
01/2020 - 10/2013
5Pemphigus (Pemphigus Vulgaris)
04/2016 - 04/2009
4Pruritus (Itching)
09/2021 - 02/2011
4Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/2020 - 02/2017
4Erythema Multiforme
03/2016 - 09/2006
4Necrosis
01/2012 - 02/2007
3Wounds and Injuries (Trauma)
01/2022 - 12/2012
3B-Cell Lymphoma (Lymphoma, B Cell)
04/2021 - 11/2009
3Disease Progression
07/2020 - 10/2018
3Hypertriglyceridemia
07/2019 - 11/2010
3Bullous Pemphigoid (Pemphigoid)
02/2016 - 06/2011
3Tinea (Ringworm)
07/2013 - 01/2008
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2012 - 01/2011
3Eosinophilia
10/2010 - 10/2007
2Bites and Stings (Sting)
01/2022 - 11/2005
2Phototoxic Dermatitis (Phototoxicity)
12/2021 - 12/2005
2Fever (Fevers)
06/2021 - 01/2018
2Lymphoma (Lymphomas)
12/2020 - 06/2005
2Autoimmune Diseases (Autoimmune Disease)
01/2020 - 09/2007
2Vitiligo
10/2019 - 12/2018
2Cicatrix (Scar)
09/2019 - 11/2003
2Leukopenia
07/2019 - 02/2017
2Hypothyroidism
07/2019 - 02/2017
2Hypercholesterolemia
07/2019 - 02/2017
2Neutropenia
07/2019 - 02/2017
2Merkel Cell Carcinoma
01/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

17Pharmaceutical PreparationsIBA
09/2021 - 05/2002
16CytokinesIBA
01/2020 - 08/2002
12ChemokinesIBA
11/2014 - 04/2002
11Interleukin-17 (Interleukin 17)IBA
10/2021 - 11/2008
8AntigensIBA
01/2020 - 04/2002
8HaptensIBA
01/2020 - 04/2002
8Immunoglobulin E (IgE)IBA
01/2018 - 08/2007
7Interleukin-22 (IL-22)IBA
01/2022 - 12/2010
7Cholinergic Agents (Cholinergics)IBA
08/2021 - 11/2010
7AutoantibodiesIBA
04/2016 - 04/2009
6Immunoglobulin G (IgG)IBA
10/2018 - 04/2002
6Interferon-gamma (Interferon, gamma)IBA
01/2014 - 04/2002
5InterleukinsIBA
01/2022 - 07/2010
5InterferonsIBA
01/2022 - 01/2014
5Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2012
5DNA (Deoxyribonucleic Acid)IBA
01/2018 - 09/2004
5Ketoprofen (Orudis)FDA LinkGeneric
08/2012 - 02/2006
4Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2010
4NickelIBA
01/2020 - 03/2012
4NivolumabIBA
10/2019 - 07/2018
4calcipotriene (calcipotriol)FDA LinkGeneric
01/2017 - 09/2014
4AntibodiesIBA
04/2016 - 12/2010
4Interleukin-4 (Interleukin 4)IBA
12/2015 - 08/2007
4Prednisolone (Predate)FDA LinkGeneric
03/2013 - 02/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 10/2013
3Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2022 - 01/2009
3Cholecalciferol (Vitamin D3)FDA Link
01/2022 - 01/2016
3MetalsIBA
01/2022 - 12/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2016
3Peptides (Polypeptides)IBA
12/2021 - 12/2003
3dupilumabIBA
10/2021 - 02/2020
3Cholinergic ReceptorsIBA
01/2021 - 11/2010
3Antimicrobial PeptidesIBA
09/2019 - 12/2010
3Filaggrin ProteinsIBA
03/2019 - 05/2010
3Interleukin-23 (Interleukin 23)IBA
01/2019 - 07/2014
3Indicators and Reagents (Reagents)IBA
04/2018 - 04/2011
3betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
01/2017 - 01/2016
3Olopatadine Hydrochloride (Patanol)FDA Link
04/2015 - 07/2003
3nadifloxacinIBA
08/2013 - 05/2006
3ProstaglandinsIBA
01/2013 - 09/2007
3Chemokine ReceptorsIBA
10/2012 - 11/2007
3Methotrexate (Mexate)FDA LinkGeneric
05/2012 - 12/2003
3SteroidsIBA
12/2011 - 09/2007
2OvalbuminIBA
10/2022 - 01/2020
2Ointments (Pastes)IBA
10/2021 - 01/2009
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2021 - 02/2017
2Acetylcholine (Acetylcholine Chloride)FDA Link
01/2021 - 01/2014
2Cholecystokinin (Pancreozymin)IBA
12/2020 - 01/2019
2Vindesine (Vindesin)IBA
12/2020 - 06/2010
2secukinumabIBA
12/2020 - 10/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2020 - 06/2010
2Etoposide (VP 16)FDA LinkGeneric
12/2020 - 03/2013
2AllergensIBA
01/2020 - 06/2007
2Bexarotene (LGD1069)FDA Link
07/2019 - 02/2017
2Voriconazole (Vfend)FDA LinkGeneric
01/2019 - 01/2018

Therapy/Procedure

22Therapeutics
10/2021 - 12/2003
6Radiotherapy
12/2018 - 04/2005